ScholarIQanswers from OpenAlex

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma

PaperCitations, authors & open-access status

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma have?

ScholarIQcitation count

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma has 138 citations in the OpenAlex counts ScholarIQ stores.

When was B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma published?

ScholarIQyear

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma has 2013 year in the ScholarIQ index.

What is the open-access status of B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma?

ScholarIQoa status

B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma has bronze oa status in the ScholarIQ index.

What is the DOI of B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma?

ScholarIQdoi

The DOI for B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma is on the source record.

What is the PMID of B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma?

ScholarIQpmid

The PMID for B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma is on the source record.

What is the OpenAlex record for B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma?

ScholarIQopenalex

The OpenAlex for B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial